The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder

Journal of Psychosomatic Research

Volumn 67, Issue 6, 2009, Pages 547-557

  Martino, Davide ^a   Defazio, Giovanni ^a   Giovannoni, Gavin ^b  

^a UNIVERSITY OF BARI   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Gilles de la Tourette syndrome; Group A hemolytic streptococcus; Immunity; Obsessive compulsive disorder; PANDAS

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN V;

ANTIBIOTIC PROPHYLAXIS; ATTENTION DEFICIT DISORDER; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; GILLES DE LA TOURETTE SYNDROME; HEART DISEASE; HUMAN; IMMUNE RESPONSE; LONGITUDINAL STUDY; OBSESSIVE COMPULSIVE DISORDER; PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH STREPTOCOCCAL INFECTION; RELIABILITY; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; STREPTOCOCCUS GROUP A; TIC;

HUMANS; OBSESSIVE-COMPULSIVE DISORDER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; TIC DISORDERS; TOURETTE SYNDROME;

EID: 70449424889     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2009.07.004     Document Type: Review

References (82)

1. Swain J.E., Scahill L., Lombroso P.J., King R.A., and Leckman J.F. Tourette syndrome and tic disorders: a decade of progress. J Am Acad Child Adolesc Psychiatry 46 (2007) 947-968
2. Swedo S.E. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 272 (1994) 1788-1791
3. Jordan L.C., and Singer H.S. Sydenham chorea in children. Curr Treat Options Neurol 5 (2003) 283-290
4. Kiessling L.S., Marcotte A.C., and Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 92 (1993) 39-43
5. Swedo S.E., Leonard H.L., Garvey M., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155 (1998) 264-271
6. Kurlan R., and Kaplan E.L. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: hypothesis or entity? Practical considerations for the clinician. Pediatrics 113 (2004) 883-886
7. Swedo S.E., Leonard H.L., and Rapoport J.L. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics 113 (2004) 907-911
8. Gabbay V., Coffey B.J., Babb J.S., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcus: comparison of diagnosis and treatment in the community and at a specialty clinic. Pediatrics 122 (2008) 273-278
9. Cardona F., and Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr 138 (2001) 71-75
10. Morshed S.A., Parveen S., Leckman J.F., et al. Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry 50 (2001) 566-577
11. Muller N., Riedel M., Straube A., et al. Increased antistreptococcal antibodies in patients with Tourette's syndrome. Psychiatry Res 94 (2000) 43-49
12. Muller N., Kroll B., Schwarz M.J., et al. Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome. Psychiatry Res 101 (2001) 187-193
13. Church A.J., Dale R.C., Lees A.J., Giovannoni G., and Robertson M.M. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 74 (2003) 602-607
14. Martino D., Church A.J., Defazio G., et al. Soluble adhesion molecules in Gilles de la Tourette's syndrome. J Neurol Sci 234 (2005) 79-95
15. Rizzo R., Gulisano M., Pavone P., Fogliani F., and Robertson M.M. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study. J Child Neurol 21 (2006) 747-753
16. Loiselle C.R., Wendlandt J.T., Rohde C.A., and Singer H.S. Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome. Pediatr Neurol 28 (2003) 119-125
17. Cardona F., Ventriglia F., Cipolla O., Romano A., Creti R., and Orefici G. A post-streptococcal pathogenesis in children with tic disorders is suggested by a color Doppler echocardiographic study. Eur J Paediatr Neurol 11 (2007) 270-276
18. Snider L.A., Sachdev V., MacKaronis J.E., St. Peter M., and Swedo S.E. Echocardiographic findings in the PANDAS subgroup. Pediatrics 114 (2004) e748-e751
19. Segarra A.R., and Murphy T.K. Cardiac involvement in children with PANDAS. J Am Acad Child Adolesc Psychiatry 47 (2008) 603-604
20. Giulino L., Gammon P., Sullivan K., et al. Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?. J Child Adolesc Psychopharmacol 12 (2002) 157-164
21. Mell L.K., Davis R.L., and Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 116 (2005) 56-60
22. Leslie D.L., Kozma L., Martin A., et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry (2008) [Epub ahead of print]
23. Murphy M.L., and Pichichero M.E. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 156 (2002) 356-361
24. Luo F., Leckman J.F., Katsovich L., et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 113 (2004) e578-e585
25. Perrin E.M., Murphy M.L., Casey J.R., et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?. Arch Pediatr Adolesc Med 158 (2004) 848-856
26. March J.S. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): implications for clinical practice. Arch Pediatr Adolesc Med 158 (2004) 927-929
27. Murphy T.K., Sajid M., Soto O., et al. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry 55 (2004) 61-68
28. Kurlan R., Johnson D., Kaplan E.L., and and the Tourette Syndrome Study Group. Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics 121 (2008) 1188-1197
29. Murphy T.K., Snider L.A., Mutch P.J., et al. Relationship of movements and behaviors to group A Streptococcus infections in elementary school children. Biol Psychiatry 61 (2007) 279-284
30. Waldrep D.A. Two cases of ADHD following GABHS infection: a PANDAS subgroup?. J Am Acad Child Adolesc Psychiatry 41 (2002) 1273-1274
31. Peterson B.S., Leckman J.F., Tucker D., et al. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Arch Gen Psychiatry 57 (2000) 364-372
32. Mercadante M.T., Busatto G.F., Lombroso P.J., et al. The psychiatric symptoms of rheumatic fever. Am J Psychiatry 157 (2000) 2036-2038
33. Dale R.C., Heyman I., Surtees R., et al. Dyskinesias and associated psychiatric disorders following streptococcal infections. Arch Dis Child 89 (2004) 604-610
34. Elia J., Dell M.L., Friedman D.F., et al. PANDAS with catatonia: a case report. Therapeutic response to lorazepam and plasmapheresis. J Am Acad Child Adolesc Psychiatry 44 (2005) 1145-1150
35. Kerbeshian J., Burd L., and Tait A. Chain reaction or time bomb: a neuropsychiatric-developmental/neurodevelopmental formulation of tourettisms, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS. World J Biol Psychiatry 8 (2007) 201-207
36. Mathew S.J. PANDAS variant and body dysmorphic disorder. Am J Psychiatry 158 (2001) 963
37. Sokol M.S. Infection-triggered anorexia nervosa in children: clinical description of four cases. J Child Adolesc Psychopharmacol 10 (2000) 133-145
38. Calkin C.V., and Carandang C.G. Certain eating disorders may be a neuropsychiatric manifestation of PANDAS: case report. J Am Acad Child Adolesc Psychiatry 16 (2007) 132-135
39. Puxley F., Midtsund M., Iosif A., and Lask B. PANDAS anorexia nervosa-endangered, extinct or nonexistent?. Int J Eat Disord 41 (2008) 15-21
40. Kuluva J., Hirsch S., and Coffey B. PANDAS and paroxysms: a case of conversion disorder?. J Child Adolesc Psychopharmacol 18 (2008) 109-115
41. Hirschtritt M.E., Hammond C.J., Luckenbaugh D., et al. Executive and attention functioning among children in the PANDAS subgroup. Child Neuropsychol 11 (2008) 1-16
42. Kirvan C.A., Swedo S.E., Kurahara D., and Cunningham M.W. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity 39 (2006) 21-29
43. Pavone P., Bianchini R., Parano E., et al. Anti-brain antibodies in PANDAS versus uncomplicated streptococcal infection. Pediatr Neurol 30 (2004) 107-110
44. Morris C.M., Pardo-Villamizar C., Gause C.D., and Singer H.S. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci (2008) [Epub ahead of print]
45. Kirvan C.A., Swedo S.E., Snider L.A., and Cunningham M.W. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 179 (2006) 173-179
46. Church A.J., Dale R.C., and Giovannoni G. Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?. Arch Dis Child 89 (2004) 611-614
47. Singer H.S., Loiselle C.R., Lee O., Minzer K., Swedo S., and Grus F.H. Anti-basal ganglia antibodies in PANDAS. Mov Disord 19 (2004) 406-415
48. Singer H.S., Hong J.J., Yoon D.Y., and Williams P.N. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 65 (2005) 1701-1707
49. Martino D., Church A.J., Dale R.C., and Giovannoni G. Antibasal ganglia antibodies and PANDAS. Mov Disord 20 (2005) 116-117
50. Dale R.C., Church A.J., Candler P.M., Chapman M., Martino D., and Giovannoni G. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 66 (2006) 1612
51. Dale R.C., Candler P.M., Church A.J., Wait R., Pocock J.M., and Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 172 (2006) 187-197
52. Kansy J.W., Katsovich L., McIver K.S., et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 181 (2006) 165-176
53. Kirvan C.A., Swedo S.E., Heuser J.S., and Cunningham M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 9 (2003) 914-920
54. Archelos J.J., and Hartung H.P. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci 23 (2000) 317-327
55. Giedd J.N., Rapoport J.L., Garvey M.A., Perlmutter S., and Swedo S.E. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry 157 (2000) 281-283
56. Hallett J.J., Harling-Berg C.J., Knopf P.M., Stopa E.G., and Kiessling L.S. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. J Neuroimmunol 111 (2000) 195-202
57. Taylor J.R., Morshed S.A., Parveen S., et al. An animal model of Tourette's syndrome. Am J Psychiatry 159 (2002) 657-660
58. Loiselle C.R., Lee O., Moran T.H., and Singer H.S. Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes. Mov Disord 19 (2004) 390-396
59. Singer H.S., Mink J.W., Loiselle C.R., et al. Microinfusion of antineuronal antibodies into rodent striatum: failure to differentiate between elevated and low titers. J Neuroimmunol 163 (2005) 8-14
60. Liu X., Wang Y., Li D., and Ju X. Transplantation of rat neural stem cells reduces stereotypic behaviors in rats after intrastriatal microinfusion of Tourette syndrome sera. Behav Brain Res 186 (2008) 84-90
61. Hoffman K.L., Hornig M., Yaddanapudi K., Jabado O., and Lipkin W.I. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J Neurosci 24 (2004) 1780-1791
62. Leckman J.F., Katsovich L., Kawikova I., et al. Increased serum levels of tumour necrosis factor-alpha and IL-12 in Tourette's syndrome. Biol Psychiatry 57 (2005) 667-673
63. Lit L., Gilbert D.L., Walker W., and Sharp F.R. A subgroup of Tourette's patients overexpress specific natural killer cell genes in blood: a preliminary report. Am J Med Genet B 144B (2007) 958-963
64. Kawikova I., Leckman J.F., Kronig H., et al. Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry 61 (2007) 273-278
65. Singer H.S., Gause C., Morris C., Lopez P., and Tourette Syndrome Study Group. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 121 (2008) 1198-1205
66. Garvey M.A., Perlmutter S.J., Allen A.J., et al. A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45 (1999) 1564-1571
67. Snider L.A., Lougee L., Slattery M., et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 57 (2005) 788-792
68. Budman C., Coffey B.J., Dure L., et al. Regarding "antibiotic prophylaxis with azithromycin or penicillin for childhhod-onset neuropsychiatric disorders". Biol Psychiatry 58 (2005) 917
69. Garvey M.A., Swedo S.E., Shapiro M.B., et al. Intravenous immunoglobulin and plasmapheresis as effective treatments of Sydenham's corea. [abstract]. Neurology 46 (1996) A147
70. Perlmutter S.J., Leitman S.F., Garvey M.A., et al. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354 (1999) 1153-1158
71. Singer H.S. PANDAS and immunomodulatory therapy. Lancet 354 (1999) 1137-1138
72. Kondo K., and Kabasawa T. Improvement in Gilles de la Tourette syndrome after corticosteroid therapy. Ann Neurol 4 (1978) 387
73. Geschwind N., and Kondo K. Corticosteroid therapy and Tourette syndrome. Ann Neurol 5 (1979) 495
74. Matarazzo E.B. Tourette's syndrome treated with ACTH and prednisone: report of two cases. J Child Adolesc Psychopharmacol 2 (1992) 215-226
75. Allen A.J., Leonard H.L., and Swedo S.E. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 34 (1995) 307-311
76. Tucker D.M., Leckman J.F., Scahill L., et al. A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified. J Am Acad Child Adolesc Psychiatry 35 (1996) 1684-1691
77. Muller N., Riedel M., Erfurth A., et al. Immunoglobulin therapy in Gilles de la Tourette syndrome. Nervenarzt 68 (1997) 914-916
78. Perlmutter S.J., Garvey M.A., Castellanos X., et al. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Am J Psychiatry 155 (1998) 1592-1598
79. Hoekstra P.J., Minderaa R.B., and Kallenberg C.G.M. Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study. J Clin Psychiatry 65 (2004) 537-542
80. Nicolson R., Swedo S.E., Lenane M., et al. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations. J Am Acad Child Adolesc Psychiatry 39 (2000) 1313-1315
81. Murphy T.K., Storch E.A., and Strawser M. SSRI-induced behavioral activation in the PANDAS subtype. Prim Psychiatry 13 (2006) 87-89
82. Storch E.A., Murphy T.K., Geffken G.R., et al. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry 45 (2006) 1171-1178